Rivaroxaban

Name: Rivaroxaban | 366789-02-8
Brand: US-CATO
SKU: S57C4X-1090_10_MG
Price: 19998.0 USD
Availability: OutOfStock

Cat. No S57C4X-1090_10_MG

Vendor: US-CATO

Product Information

Product Name

Rivaroxaban

Brand Name

US-CATO

Product Number

C4X-1090

CAS

366789-02-8

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

9875401

IUPAC Name

5-chloro-N-(5S)-2-oxo-3-4-(3-oxomorpholin-4-yl)phenyl-1,3-oxazolidin-5-ylmethylthiophene-2-carboxamide

InChI Key

KGFYHTZWPPHNLQ-AWEZNQCLSA-N

SMILES

C1COCC(=O)N1C2=CC=C(C=C2)N3CC@@H(OC3=O)CNC(=O)C4=CC=C(S4)Cl

References Data Source From Pubchem

Author response to Zupan et al., Letter to the editor regarding “Intracranial hemorrhage after ischemic stroke in patients on direct oral anticoagulants: results from a prospective observational study” by Purrucker et al

Publication Name: Neurological Research and Practice

Publication Date: 2026-06-22

DOI: 10.1186/s42466-026-00462-y|10.1186/s42466-026-00483-7|10.1186/s42466-026-00495-3

[More than just purpura-Immunoglobulin A vasculitis in adulthood]

Publication Name: Innere Medizin (Heidelberg, Germany)

Publication Date: 2026-06

DOI: 10.1007/s00108-026-02060-1

Patient Preferences in Anticoagulation Treatment: A Review of Discrete Choice Experiments

Publication Name: The Patient - Patient-Centered Outcomes Research

Publication Date: 2026-05

DOI: 10.1007/s40271-025-00792-0

[Acute venous disorders: deep vein thrombosis and superficial vein thrombosis of the lower extremity : Diagnosis and treatment in dermatology practice]

Publication Name: Dermatologie (Heidelberg, Germany)

Publication Date: 2026-05

DOI: 10.1007/s00105-026-05655-9

A streamlined in-syringe fast drug extraction and semi-automated dispersive cleanup technique for quick biomonitoring of direct oral anti-coagulant drugs in patients’ plasma samples using UHPLC-MS/MS analysis

Publication Name: Analytical and Bioanalytical Chemistry

Publication Date: 2026-03-05

DOI: 10.1007/s00216-026-06348-x

Rivaroxaban

Product Information

General Information

References Data Source From Pubchem

Author response to Zupan et al., Letter to the editor regarding “Intracranial hemorrhage after ischemic stroke in patients on direct oral anticoagulants: results from a prospective observational study” by Purrucker et al

[More than just purpura-Immunoglobulin A vasculitis in adulthood]

Patient Preferences in Anticoagulation Treatment: A Review of Discrete Choice Experiments

[Acute venous disorders: deep vein thrombosis and superficial vein thrombosis of the lower extremity : Diagnosis and treatment in dermatology practice]

A streamlined in-syringe fast drug extraction and semi-automated dispersive cleanup technique for quick biomonitoring of direct oral anti-coagulant drugs in patients’ plasma samples using UHPLC-MS/MS analysis

Rivaroxaban

Mycophenolate Mofetil EP Impurity H

Mycophenolate Mofetil

Flurbiprofen Impurity 21 (Mixture of Diastereomers)

Docetaxel Impurity 40

H-Met-Glu-OH

Fluticasone Impurity 106

Efavirenz Related Compound C

Cholecalciferol EP Impurity A

About Us

Popular Searches

Contact

#title#

Features
Availability:
Price
Options
Actions

Rivaroxaban

Product Information

General Information

References Data Source From Pubchem

Author response to Zupan et al., Letter to the editor regarding “Intracranial hemorrhage after ischemic stroke in patients on direct oral anticoagulants: results from a prospective observational study” by Purrucker et al

[More than just purpura-Immunoglobulin A vasculitis in adulthood]

Patient Preferences in Anticoagulation Treatment: A Review of Discrete Choice Experiments

[Acute venous disorders: deep vein thrombosis and superficial vein thrombosis of the lower extremity : Diagnosis and treatment in dermatology practice]

A streamlined in-syringe fast drug extraction and semi-automated dispersive cleanup technique for quick biomonitoring of direct oral anti-coagulant drugs in patients’ plasma samples using UHPLC-MS/MS analysis

Rivaroxaban

Related Product

Mycophenolate Mofetil EP Impurity H

Mycophenolate Mofetil

Flurbiprofen Impurity 21 (Mixture of Diastereomers)

Docetaxel Impurity 40

H-Met-Glu-OH

Fluticasone Impurity 106

Efavirenz Related Compound C

Cholecalciferol EP Impurity A

#title#

Login

Register